ClinicalTrials HQ

Muscular dystrophy congenital, merosin negative

Muscular dystrophy congenital, merosin negative

Explore linked clinical trials. Standard reference: MESH:M0531845
View definition

5 results · Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular DystrophyMuscular dystrophy congenital, merosin negativeRecruitingNot stated2026-08-19NCT06503367
Preclinical Assessment of an Engineered HMGB1 Protein as a Novel Companion Therapy for Muscular DystrophiesMuscular dystrophy congenital, merosin negativeRecruitingNot stated2026-08-04NCT07745218
Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease BiomarkersMuscular dystrophy congenital, merosin negativeRecruitingNot stated2025-08-15NCT07125040
Spanish Natural History Study for LAMA2 Muscular DystrophyCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, Muscular dystrophy congenital, merosin negative, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular diseaseRecruitingNot stated2025-04-11NCT06924125
Natural History Study of Children With LAMA2-related DystrophiesMuscular dystrophy congenital, merosin negativeRecruitingNot stated2024-12-12NCT06354790